Coblopasvir and sofosbuvir treatment for Chinese patients with chronic HCV infection is safe and efficacious: a real-world study

coblopasvir (KW 136) - Beijing Kawin

Sovaldi (sofosbuvir) - Gilead

https://www.apasl2025beijing.com/download/APASL2025-AbstractBook.pdf

Zhiyan Pei 1; Aidi Ma 1; Yuanyuan Liu 1; Tianfu Liu 1; Yaping Zhang 1; Longquan Li 1; Yongfang Li 1; Yin Kong 1; Juan Li 1; Jie Ding 1; Jingjing He 1; Guangming Li 1; Rui Zhao 1; Lingyi Zhang 2

Feb 20, 2025